Does REVLIMID Cause Basal cell carcinoma? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Basal cell carcinoma have been filed in association with REVLIMID. This represents 0.2% of all adverse event reports for REVLIMID.
19
Reports of Basal cell carcinoma with REVLIMID
0.2%
of all REVLIMID reports
1
Deaths
3
Hospitalizations
How Dangerous Is Basal cell carcinoma From REVLIMID?
Of the 19 reports, 1 (5.3%) resulted in death, 3 (15.8%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REVLIMID. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does REVLIMID Cause?
Pneumonia (652)
Plasma cell myeloma (632)
Death (565)
Diarrhoea (508)
Thrombosis (484)
Fatigue (448)
Platelet count decreased (362)
Full blood count decreased (352)
Deep vein thrombosis (332)
Pancytopenia (319)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which REVLIMID Alternatives Have Lower Basal cell carcinoma Risk?
REVLIMID vs REVOLADE
REVLIMID vs REVUMENIB
REVLIMID vs REYATAZ
REVLIMID vs REZAFUNGIN
REVLIMID vs RIBASPHERE